Remogliflozin represents a key category of compounds based on this SGLT2 inhibitor, a therapeutic agent primarily used in the management of type 2 diabetes mellitus and investigations into non-alcoholic… Read more

Remogliflozin represents a key category of compounds based on this SGLT2 inhibitor, a therapeutic agent primarily used in the management of type 2 diabetes mellitus and investigations into non-alcoholic steatohepatitis. Pharmaceutical laboratories rely on accurate reference standards of the active ingredient, its metabolites, and associated impurities for comprehensive impurity profiling and method validation. This collection includes a variety of relevant derivatives, including specific epimers, pyrazolone impurities, and the etabonate prodrug, all of which are critical for characterizing chemical stability and monitoring potential degradation pathways. Furthermore, stable isotope labelled versions of the molecule are essential for use as internal standards in mass spectrometry-based bioanalysis. By incorporating these materials into routine testing protocols, analysts ensure reliable quality control and regulatory compliance throughout the lifecycle of drug product development.